Aquaculture Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Route of Administration (Oral, Injected, Immersion & Spray), By Application (Bacterial, Viral, Parasitic), By Region and Competition, 2020-2030F

December 2025 | 183 pages | ID: A409342F88E6EN
TechSci Research

Abstracts

The Global Aquaculture Vaccines Market, valued at USD 399.49 Million in 2024, is projected to experience a CAGR of 7.95% to reach USD 632.18 Million by 2030. Aquaculture vaccines are biological preparations administered to farmed aquatic animals to prevent and control infectious diseases, thereby enhancing animal health and production efficiency. The global aquaculture vaccines market is primarily driven by the escalating demand for aquatic food products, leading to intensified farming practices and a subsequent rise in disease prevalence.

Key Market Drivers

The aquaculture vaccines market expansion is significantly influenced by the high prevalence of infectious diseases within aquaculture production systems. Intensive farming practices, necessary to meet increasing global demand for aquatic food products, create environments where pathogens spread rapidly, leading to substantial economic losses and threatening food security. These outbreaks necessitate effective prophylactic solutions to maintain animal health and production stability.

Key Market Challenges

A significant challenge impeding the growth of the global aquaculture vaccines market stems from the substantial research and development costs required for new vaccine creation. This financial burden is notably intensified by the extensive biological diversity among aquaculture species and the multitude of pathogens they encounter. Developing effective vaccines for a wide array of species, each with unique immunological responses, demands considerable resources and specialized expertise.

Key Market Trends

Geographic expansion into emerging aquaculture markets represents a significant trend, driven by the increasing global demand for aquatic protein and the potential for aquaculture development in previously underserved regions. These emerging markets, particularly in Africa, offer substantial growth opportunities due to rising populations, improving economic conditions, and government initiatives to enhance food security.

Key Market Players

• Zoetis Inc.
• Phibro Animal Health Corporation
• Elanco Animal Health Incorporated
• Merck KGaA
• KBNP Inc.
• UNILINE GROUP FOR VETERINARY EQUIPMENT
• Kyoto Biken Laboratories, Inc.
• Nisseiken Co., Ltd.
• Vaxxinova International BV
• HIPRA SA

Report Scope:

In this report, the Global Aquaculture Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Aquaculture Vaccines Market, By Product:
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Aquaculture Vaccines Market, By Route of Administration:
• Oral
• Injected
• Immersion & Spray
• Aquaculture Vaccines Market, By Application:
• Bacterial
• Viral
• Parasitic
• Aquaculture Vaccines Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Aquaculture Vaccines Market.

Available Customizations:

Global Aquaculture Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL AQUACULTURE VACCINES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  5.2.2. By Route of Administration (Oral, Injected, Immersion & Spray)
  5.2.3. By Application (Bacterial, Viral, Parasitic)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA AQUACULTURE VACCINES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Route of Administration
  6.2.3. By Application
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Aquaculture Vaccines Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Route of Administration
      6.3.1.2.3. By Application
  6.3.2. Canada Aquaculture Vaccines Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Route of Administration
      6.3.2.2.3. By Application
  6.3.3. Mexico Aquaculture Vaccines Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Route of Administration
      6.3.3.2.3. By Application

7. EUROPE AQUACULTURE VACCINES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Route of Administration
  7.2.3. By Application
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Aquaculture Vaccines Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Route of Administration
      7.3.1.2.3. By Application
  7.3.2. France Aquaculture Vaccines Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Route of Administration
      7.3.2.2.3. By Application
  7.3.3. United Kingdom Aquaculture Vaccines Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Route of Administration
      7.3.3.2.3. By Application
  7.3.4. Italy Aquaculture Vaccines Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Route of Administration
      7.3.4.2.3. By Application
  7.3.5. Spain Aquaculture Vaccines Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Route of Administration
      7.3.5.2.3. By Application

8. ASIA PACIFIC AQUACULTURE VACCINES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Route of Administration
  8.2.3. By Application
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Aquaculture Vaccines Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Route of Administration
      8.3.1.2.3. By Application
  8.3.2. India Aquaculture Vaccines Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Route of Administration
      8.3.2.2.3. By Application
  8.3.3. Japan Aquaculture Vaccines Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Route of Administration
      8.3.3.2.3. By Application
  8.3.4. South Korea Aquaculture Vaccines Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Route of Administration
      8.3.4.2.3. By Application
  8.3.5. Australia Aquaculture Vaccines Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Route of Administration
      8.3.5.2.3. By Application

9. MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Route of Administration
  9.2.3. By Application
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Aquaculture Vaccines Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Route of Administration
      9.3.1.2.3. By Application
  9.3.2. UAE Aquaculture Vaccines Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Route of Administration
      9.3.2.2.3. By Application
  9.3.3. South Africa Aquaculture Vaccines Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Route of Administration
      9.3.3.2.3. By Application

10. SOUTH AMERICA AQUACULTURE VACCINES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Route of Administration
  10.2.3. By Application
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Aquaculture Vaccines Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Route of Administration
      10.3.1.2.3. By Application
  10.3.2. Colombia Aquaculture Vaccines Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Route of Administration
      10.3.2.2.3. By Application
  10.3.3. Argentina Aquaculture Vaccines Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Route of Administration
      10.3.3.2.3. By Application

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL AQUACULTURE VACCINES MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Zoetis Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Phibro Animal Health Corporation
15.3. Elanco Animal Health Incorporated
15.4. Merck KGaA
15.5. KBNP Inc.
15.6. UNILINE GROUP FOR VETERINARY EQUIPMENT
15.7. Kyoto Biken Laboratories, Inc.
15.8. Nisseiken Co., Ltd.
15.9. Vaxxinova International BV
15.10. HIPRA SA

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER